CT Financial Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$260K Sell
4,285
-676
-14% -$41K 0.16% 129
2016
Q4
$279K Sell
4,961
-48
-1% -$2.81K 0.18% 121
2016
Q3
$298K Hold
5,009
0.18% 110
2016
Q2
$275K Hold
5,009
0.17% 115
2016
Q1
$253K Hold
5,009
0.14% 123
2015
Q4
$252K Hold
5,009
0.15% 124
2015
Q3
$236K Hold
5,009
0.15% 122
2015
Q2
$272K Hold
5,009
0.15% 120
2015
Q1
$275K Hold
5,009
0.15% 121
2014
Q4
$271K Buy
+5,009
New +$279K 0.21% 91
2014
Q1
$275K Buy
+5,009
New +$259K 0.15% 121

Other funds holding MRK

CT Financial Advisors's MRK Position: Q1 2017 in Review

CT Financial Advisors reduced its Merck (MRK) stake by 14% in Q1 2017, selling an estimated $41K and leaving 4,285 shares worth $260K. The position accounts for 0.16% of the portfolio, ranked #129.

CT Financial Advisors first reported a position in MRK in Q1 2014 and has held it in 11 quarters since. The position peaked at $298K in Q3 2016. 1,941 funds tracked by Wall St. Rank hold MRK as of Q1 2017.

  • CT Financial Advisors held 4,285 shares of Merck worth $260K as of Q1 2017.
  • CT Financial Advisors sold 676 Merck shares in Q1 2017, an estimated $41K.
  • Merck made up 0.16% of CT Financial Advisors's portfolio in Q1 2017, its #129 holding.
  • CT Financial Advisors first reported a position in Merck in Q1 2014 and has held it in 11 quarters since.
  • CT Financial Advisors's Merck position peaked at $298K in Q3 2016.
  • 1,941 funds tracked by Wall St. Rank held Merck as of Q1 2017.

Based on CT Financial Advisors's 13F filing for Q1 2017, filed 7 Apr 2017.